Tharimmune Announces Positive Results Of Phase 1 Trial In Healthy Subjects With TH104, Its Lead Candidate For Moderate-to-Severe Pruritus In Primary Biliary Cholangitis : Comparemela.com

Tharimmune Announces Positive Results of Phase 1 Trial in Healthy Subjects with TH104, its Lead Candidate for Moderate-to-Severe Pruritus in Primary Biliary Cholangitis

Tharimmune Announces Positive Results of Phase 1 Trial in Healthy Subjects with TH104, its Lead Candidate for Moderate-to-Severe Pruritus in Primary Biliary Cholangitis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United Kingdom , Bridgewater , Somerset , British , Tirtht Patel , Randy Milby , Omniab Inc , Tharimmune Inc , Nasdaq , Exchange Commission , Chief Executive Officer , Private Securities Litigation Reform Act , Risk Factors , Annual Report , Clinical Pharmacology ,

comparemela.com © 2020. All Rights Reserved.